I'm glad to see we have pretty much the same viewpoint. I also believe many of the long's here has relayed their information as they have received, but I also have personally watched previous deceptions (by the companies themselves or by overzealous investors) in the arena of non-invasive diagnostic medicine, particularly BICO and Futrex. The present viewpoints of CCSI longs have yet to be proven out, while the examples of BICO and Futrex are well documented. Not knowing anyone personally on this thread, my money sides with documentable history and what I believe to be tried and true investment philosophy.
Based on that, for those of us on the sidelines, more hard and definitive information is required before an initial investment will be made. My personal belief is that new investors will stay away from CCSI until either the deal is announced or the risk/reward ratio for CCSI becomes obscene (for me, below $5, more likely in the $2-$4 range, where I feel the company would be worth once the technology is adapted for the dental application solely). The more aggressive of present investors will be waiting to pick the bottom to maximize their payback. For those still strong in their beliefs in the CCSI story and prudent in their investment strategy, some averaging down will be in order. If the announcement is made this week and is as good as some say, then it will indeed be payday this week for those who are long when that announcement is made. However, if I owned CCSI on margin, I would seriously consider contingencies at this time particularly if CCSI and their PR firm do nothing in the afterhours today to defend this stock. I assume many of you that are heavily invested in this stock have flooded the phones with your concerns today and if a defense is available, it will be forthcoming.
As you say, we now have to wait and see what the real story is.
Good luck to all!
Rockin' Robin |
